Miles A. Miller

5.2k total citations · 1 hit paper
77 papers, 3.9k citations indexed

About

Miles A. Miller is a scholar working on Molecular Biology, Oncology and Biomedical Engineering. According to data from OpenAlex, Miles A. Miller has authored 77 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 27 papers in Oncology and 20 papers in Biomedical Engineering. Recurrent topics in Miles A. Miller's work include Nanoplatforms for cancer theranostics (11 papers), Peptidase Inhibition and Analysis (10 papers) and Immune cells in cancer (10 papers). Miles A. Miller is often cited by papers focused on Nanoplatforms for cancer theranostics (11 papers), Peptidase Inhibition and Analysis (10 papers) and Immune cells in cancer (10 papers). Miles A. Miller collaborates with scholars based in United States, Germany and Singapore. Miles A. Miller's co-authors include Ralph Weissleder, Rainer H. Köhler, Mikäel J. Pittet, Douglas A. Lauffenburger, Katherine S. Yang, Michael F. Cuccarese, Camilla Engblom, Christina Pfirschke, Bjorn Askevold and Christopher Garris and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Advanced Materials.

In The Last Decade

Miles A. Miller

77 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

In vivo imaging reveals a tumor-associated macrophage–mediated resistance pathway in anti–PD-1 therapy

2017 504 citations Sean P. Arlauckas, Christopher Garris et al. Science Translational Medicine profile →

Peers

Miles A. Miller

ONCOL

IMMUN

BIOMA

Katherine S. Yang United States

Shiladitya Sengupta United States

Kun Cheng United States

Simon T. Barry United Kingdom

David C. Blakey United Kingdom

Ran Wei China

Andreas Wicki Switzerland

Kenneth L. Pitter United States

Todd A. Aguilera United States

Mahaveer S. Bhojani United States

Katherine S. Yang United States

Miles A. Miller

1.5k ×1.1

783 ×0.6

786 ×0.7

ONCOL

616 ×0.6

IMMUN

407 ×0.5

BIOMA

Citations per year, relative to Miles A. Miller Miles A. Miller (= 1×) peers Katherine S. Yang

Countries citing papers authored by Miles A. Miller

Since Specialization

Citations

This map shows the geographic impact of Miles A. Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miles A. Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miles A. Miller more than expected).

Fields of papers citing papers by Miles A. Miller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miles A. Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miles A. Miller. The network helps show where Miles A. Miller may publish in the future.

Co-authorship network of co-authors of Miles A. Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Miles A. Miller. A scholar is included among the top collaborators of Miles A. Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miles A. Miller. Miles A. Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ng, Thomas S.C., et al.. (2025). Radiation-Triggered Payload Release Enhances Bispecific Antibody Efficacy. Cancer Research. 86(2). 453–466. 1 indexed citations

Hu, Huiyu, Thomas S.C. Ng, Mikyung Kang, et al.. (2023). Thyroid Cancers Exhibit Oncogene-Enhanced Macropinocytosis that Is Restrained by IGF1R and Promote Albumin–Drug Conjugate Response. Clinical Cancer Research. 29(17). 3457–3470. 5 indexed citations

Hu, Huiyu, et al.. (2022). Radiation Cleaved Drug-Conjugate Linkers Enable Local Payload Release. Bioconjugate Chemistry. 33(8). 1474–1484. 21 indexed citations

Oh, Juhyun, Rainer H. Köhler, Hannah Peterson, et al.. (2022). Dual Immunostimulatory Pathway Agonism through a Synthetic Nanocarrier Triggers Robust Anti‐Tumor Immunity in Murine Glioblastoma. Advanced Materials. 35(7). e2208782–e2208782. 33 indexed citations

Lauffenburger, Douglas A., et al.. (2021). Cell–cell communication networks in tissue: Toward quantitatively linking structure with function. Current Opinion in Systems Biology. 27. 100341–100341. 3 indexed citations

Li, Ran, Thomas S.C. Ng, Stephanie J. Wang, et al.. (2021). Therapeutically reprogrammed nutrient signalling enhances nanoparticulate albumin bound drug uptake and efficacy in KRAS-mutant cancer. Nature Nanotechnology. 16(7). 830–839. 94 indexed citations

Li, Ran, Stephanie Wang, Mark Prytyskach, et al.. (2020). In vivo microscopy reveals macrophage polarization locally promotes coherent microtubule dynamics in migrating cancer cells. Nature Communications. 11(1). 3521–3521. 19 indexed citations

Wang, Stephanie J., Ran Li, Thomas S.C. Ng, et al.. (2020). Efficient blockade of locally reciprocated tumor-macrophage signaling using a TAM-avid nanotherapy. Science Advances. 6(21). eaaz8521–eaaz8521. 24 indexed citations

Arlauckas, Sean P., Christopher Garris, Rainer H. Köhler, et al.. (2017). In vivo imaging reveals a tumor-associated macrophage–mediated resistance pathway in anti–PD-1 therapy. Science Translational Medicine. 9(389). 504 indexed citations breakdown →

10.

Miller, Miles A., Eunha Kim, Michael F. Cuccarese, et al.. (2017). Near infrared imaging of Mer tyrosine kinase (MERTK) using MERi-SiR reveals tumor associated macrophage uptake in metastatic disease. Chemical Communications. 54(1). 42–45. 21 indexed citations

11.

Miller, Miles A., Ravi A. Chandra, Michael F. Cuccarese, et al.. (2017). Radiation therapy primes tumors for nanotherapeutic delivery via macrophage-mediated vascular bursts. Science Translational Medicine. 9(392). 184 indexed citations

12.

Yoneyama, Toshie, Michael C. Gorry, Miles A. Miller, et al.. (2017). Modification of proteolytic activity matrix analysis (PrAMA) to measure ADAM10 and ADAM17 sheddase activities in cell and tissue lysates. Journal of Cancer. 8(19). 3916–3932. 3 indexed citations

13.

Oudin, Madeleine J., Claudia Schäfer, Tatsiana Kosciuk, et al.. (2016). MENA Confers Resistance to Paclitaxel in Triple-Negative Breast Cancer. Molecular Cancer Therapeutics. 16(1). 143–155. 34 indexed citations

14.

Miller, Miles A., Madeleine J. Oudin, Ryan J. Sullivan, et al.. (2016). Reduced Proteolytic Shedding of Receptor Tyrosine Kinases Is a Post-Translational Mechanism of Kinase Inhibitor Resistance. Cancer Discovery. 6(4). 382–399. 138 indexed citations

15.

Miller, Miles A., Ryan J. Sullivan, & Douglas A. Lauffenburger. (2016). Molecular Pathways: Receptor Ectodomain Shedding in Treatment, Resistance, and Monitoring of Cancer. DSpace@MIT (Massachusetts Institute of Technology). 1 indexed citations

16.

Miller, Miles A., Yao‐Rong Zheng, Suresh Gadde, et al.. (2015). Tumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt(IV) pro-drug. Nature Communications. 6(1). 8692–8692. 366 indexed citations

17.

Jing, Tengyang, et al.. (2014). Low-volume multiplexed proteolytic activity assay and inhibitor analysis through a pico-injector array. DSpace@MIT (Massachusetts Institute of Technology). 3 indexed citations

18.

Miller, Miles A., Aaron S. Meyer, Michael T. Beste, et al.. (2013). ADAM-10 and -17 regulate endometriotic cell migration via concerted ligand and receptor shedding feedback on kinase signaling. Proceedings of the National Academy of Sciences. 110(22). E2074–83. 75 indexed citations

19.

Chen, Chia‐Hung, Miles A. Miller, Aniruddh Sarkar, et al.. (2012). High-Throughput Mutiplexed Protease Activity Measurement Using a Droplet Based Microfluidic Platform with Picoinjector. DSpace@MIT (Massachusetts Institute of Technology). 1 indexed citations

20.

Miller, Miles A.. (2001). Phase I Cancer Trials: A Crucible of Competing Priorities. International Anesthesiology Clinics. 39(3). 13–33. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact